Raymond J. Henley Iii

Array ( [id] => 3878859 [patent_doc_number] => 05798101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Herbal appetite suppressant and weight loss composition' [patent_app_type] => 1 [patent_app_number] => 8/847542 [patent_app_country] => US [patent_app_date] => 1997-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2814 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798101.pdf [firstpage_image] =>[orig_patent_app_number] => 847542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808349 [patent_doc_number] => 05854260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Enterokinetic benzamide' [patent_app_type] => 1 [patent_app_number] => 8/836276 [patent_app_country] => US [patent_app_date] => 1997-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3751 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854260.pdf [firstpage_image] =>[orig_patent_app_number] => 836276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190572 [patent_doc_number] => 06153623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Cisapride extended release' [patent_app_type] => 1 [patent_app_number] => 8/817739 [patent_app_country] => US [patent_app_date] => 1997-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2114 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153623.pdf [firstpage_image] =>[orig_patent_app_number] => 817739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809684 [patent_doc_number] => 05811437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Methods of increasing nitric oxide synthesis' [patent_app_type] => 1 [patent_app_number] => 8/840528 [patent_app_country] => US [patent_app_date] => 1997-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3540 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811437.pdf [firstpage_image] =>[orig_patent_app_number] => 840528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4066556 [patent_doc_number] => 06008259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Chemical disinfectants based on phenolic active components and glutaraldehyde' [patent_app_type] => 1 [patent_app_number] => 8/842782 [patent_app_country] => US [patent_app_date] => 1997-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1585 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008259.pdf [firstpage_image] =>[orig_patent_app_number] => 842782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744533 [patent_doc_number] => 05801193 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Compositions and methods for immunosuppressing' [patent_app_type] => 1 [patent_app_number] => 8/843401 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7130 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801193.pdf [firstpage_image] =>[orig_patent_app_number] => 843401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770309 [patent_doc_number] => 05773473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Creatine supplement' [patent_app_type] => 1 [patent_app_number] => 8/842688 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3234 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773473.pdf [firstpage_image] =>[orig_patent_app_number] => 842688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003986 [patent_doc_number] => 05859058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Nitric oxide synthase inhibitors for inhibiting the production of airway mucas' [patent_app_type] => 1 [patent_app_number] => 8/765547 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2669 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859058.pdf [firstpage_image] =>[orig_patent_app_number] => 765547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862423 [patent_doc_number] => 05795911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Composition for treating Condyloma acuminata' [patent_app_type] => 1 [patent_app_number] => 8/835920 [patent_app_country] => US [patent_app_date] => 1997-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1789 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795911.pdf [firstpage_image] =>[orig_patent_app_number] => 835920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775360 [patent_doc_number] => 05817650 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Treatment of systemic lupus erythematosus with dehydroepiandrosterone' [patent_app_type] => 1 [patent_app_number] => 8/833338 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2004 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817650.pdf [firstpage_image] =>[orig_patent_app_number] => 833338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046073 [patent_doc_number] => 05908850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Method of treating attention deficit disorders with d-threo methylphenidate' [patent_app_type] => 1 [patent_app_number] => 8/827230 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2425 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908850.pdf [firstpage_image] =>[orig_patent_app_number] => 827230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837207 [patent_doc_number] => 05707615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Method of treating HIV infections with anti-viral formulations' [patent_app_type] => 1 [patent_app_number] => 8/834697 [patent_app_country] => US [patent_app_date] => 1997-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12652 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707615.pdf [firstpage_image] =>[orig_patent_app_number] => 834697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038823 [patent_doc_number] => 05874112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Translucent antacid suspension' [patent_app_type] => 1 [patent_app_number] => 8/828622 [patent_app_country] => US [patent_app_date] => 1997-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2530 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874112.pdf [firstpage_image] =>[orig_patent_app_number] => 828622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771526 [patent_doc_number] => 05849800 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Use of amantadine for treatment of Hepatitis C' [patent_app_type] => 1 [patent_app_number] => 8/826249 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5186 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849800.pdf [firstpage_image] =>[orig_patent_app_number] => 826249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726879 [patent_doc_number] => 05700814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Sabeluzole oral suspensions' [patent_app_type] => 1 [patent_app_number] => 8/809827 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2885 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700814.pdf [firstpage_image] =>[orig_patent_app_number] => 809827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032714 [patent_doc_number] => 05994399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Method of regenerating collagen-containing tissues with misoprostol' [patent_app_type] => 1 [patent_app_number] => 8/825244 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3409 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994399.pdf [firstpage_image] =>[orig_patent_app_number] => 825244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980386 [patent_doc_number] => 05948806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Treatment of Parkinson\'s disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)' [patent_app_type] => 1 [patent_app_number] => 8/825414 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1133 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948806.pdf [firstpage_image] =>[orig_patent_app_number] => 825414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3891060 [patent_doc_number] => 05834483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Method of treating heart failure with endothelin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/824848 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 23 [patent_no_of_words] => 14725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1020 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834483.pdf [firstpage_image] =>[orig_patent_app_number] => 824848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741728 [patent_doc_number] => 05753711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Method for treatment of H. pylori' [patent_app_type] => 1 [patent_app_number] => 8/819734 [patent_app_country] => US [patent_app_date] => 1997-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2553 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753711.pdf [firstpage_image] =>[orig_patent_app_number] => 819734 [rel_patent_id] =>[rel_patent_doc_number] =>)